[Correlation between 25-hydroxyvitamin D and nephroblastoma in children and its value in assessing disease prognosis]

Li Zhao1, Xu-Kai Ma1, Yu Liu1

  • 1Department of Pediatrics, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830000, China.

Insights

Children with nephroblastoma have lower 25-hydroxyvitamin D [25-(OH)D] levels, which are linked to poorer outcomes. This vitamin D metabolite shows potential for predicting the prognosis of pediatric nephroblastoma.

Area of Science:

  • Pediatric Oncology
  • Endocrinology
  • Biochemistry

Context:

  • Nephroblastoma, a common pediatric kidney cancer, presents diagnostic and prognostic challenges.
  • Vitamin D deficiency is increasingly recognized as a factor in various diseases, including cancers.

Purpose:

  • To investigate the association between 25-hydroxyvitamin D [25-(OH)D] levels and the prognosis of nephroblastoma in children.
  • To evaluate the utility of 25-(OH)D as a predictive biomarker for pediatric nephroblastoma outcomes.

Summary:

  • Children with nephroblastoma exhibited significantly lower serum creatinine and 25-(OH)D levels compared to healthy controls.
  • Poor prognosis in nephroblastoma was associated with larger tumor size, advanced stage, metastasis, and lower 25-(OH)D levels.
  • Serum 25-(OH)D levels demonstrated a significant negative correlation with therapeutic response and were identified as a risk factor for poor prognosis.

Impact:

  • Findings suggest that 25-(OH)D levels can serve as a valuable tool for predicting nephroblastoma prognosis in children.
  • This research highlights the potential role of vitamin D status in pediatric cancer outcomes and warrants further investigation.
Abstract

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
40
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
25
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
46
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
50